Founders Fund's Delian Asparouhov: Varda lands first publicly traded pharma client, Jared Isaacman unveils sweeping NASA space policies

Summary

NASA Administrator Jared Isaacman used the Hill and Valley Forum on March 24, 2026 to unveil what Founders Fund partner Delian Asparouhov describes as the broadest reset of U.S. space policy in twenty years, branded the "Ignition" policy package.

NASA's Ignition Policy Package

The centerpiece is an aggressive lunar robotics cadence. Starting in 2027, NASA is targeting monthly robotic moon landings to run experiments on paving, energy infrastructure, communications, and regolith-based construction. The goal is to pre-position tested infrastructure before crewed missions arrive.

A second pillar is the SR-1 Freedom mission, a nuclear-powered spacecraft designed for Earth-to-Mars transit. The mission profile includes deploying four helicopters onto the Martian surface from the reentry vehicle, a configuration Asparouhov frames as operationally serious rather than speculative.

The third pillar is a formal push to ignite the low Earth orbit commercial economy, a priority Asparouhov views as directly beneficial to Varda Space Industries, his portfolio company focused on pharmaceutical manufacturing in microgravity.

Varda's First Publicly Traded Pharma Client

Varda is set to announce within the week that it has signed a publicly traded pharmaceutical company valued in the tens of billions of dollars as a recurring production client. The company will manufacture drugs for the client in space on a regular basis. Asparouhov is explicit that this is the starting line, not a milestone, for a company now five and a half years into a twenty-year plan to build the first industrial outpost in low Earth orbit.

The next hardware generation moves beyond the current satellite-plus-pod architecture toward mini space planes with larger bioreactors, with Asparouhov projecting a full space plane with onboard bioreactors on display at a 2029 event.

Lunar Ice Mining as a Near-Term Supply Chain Play

Asparouhov makes a concrete economic argument for lunar resource extraction. Water currently launched from Earth to flush Varda's orbital bioreactors is expensive. Mining lunar ice and routing it to LEO stations via mass driver would cut that cost substantially. He considers a small-scale lunar ice-melting rover that converts water to liquid hydrogen fuel for Starship plausible as early as 2027.

Founders Fund is actively tracking lunar ice mining as an investable category. Asparouhov puts better-than-even odds on the firm leading a $10 million-plus financing round into a lunar ice mining operation within five years.

SpaceX IPO as a Capital Catalyst

The combined market cap of all publicly traded space companies today sits at roughly $15 billion to $25 billion. SpaceX is expected to go public at a valuation of $1 trillion to $2 trillion. Asparouhov argues that capital rotation out of SpaceX positions into next-generation space application companies will structurally reshape funding flows across the sector.

EnduroSat Continues Profitable Anomaly

EnduroSat, a Founders Fund-backed satellite bus manufacturer operating out of a 250,000 square-foot facility in Bulgaria, remains EBITDA positive with revenue growth above 2x year-over-year. Asparouhov describes it as the only space company at its scale achieving that combination of profitability and growth.

Infrastructure Layering as the Investment Framework

Asparouhov frames the emerging space economy as a sequential infrastructure stack: reusable rockets, orbital factories, propellant depots, and persistent ground station coverage. Bridgette Mendler's Northwood is cited as an example of the ground station layer, working to give LEO operators continuous connectivity rather than the current 15-to-30-minute contact windows every three and a half hours. Application-layer companies, including space-based solar power distribution and orbital data centers, become viable only once lower infrastructure layers are in place.